As part of Open Journals’ initiatives, we create website for scholarly open access journals.
If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at
https://ejournalplus.com or send us an email to info@ejournalplus.com
The Predictive Value of Oral Nicorandil on Contrast Induced Nephropathy in Patients with Renal Insufficiency Undergoing Cardiac Catheterization in Non ST Segment Elevation Acute Coronary Syndrome
CIN leads to increased morbidity, prolonged hospital stay and thereby, more health care costs. The incidence of CIN varies from 2% to 30%. Fortunately, most cases can be completely reversed within two to four weeks. The optimal therapeutics used to prevent and CIN remains unclear. The main objective of the current study is to assess the effect of oral Nicorandil on the occurrence of CIN in patients with renal insufficiency undergoing cardiac catheterization in NSTEACS
(2021). The Predictive Value of Oral Nicorandil on Contrast Induced Nephropathy in Patients with Renal Insufficiency Undergoing Cardiac Catheterization in Non ST Segment Elevation Acute Coronary Syndrome. European Journal of Molecular & Clinical Medicine, 8(3), 331-351.
Ayman Ahmed Seleim Msc; Osama Mohamed Hassan MD; Ahmed Shawky El-serafy MD.; Ahmed Ibrahim El-Desoky MD. "The Predictive Value of Oral Nicorandil on Contrast Induced Nephropathy in Patients with Renal Insufficiency Undergoing Cardiac Catheterization in Non ST Segment Elevation Acute Coronary Syndrome". European Journal of Molecular & Clinical Medicine, 8, 3, 2021, 331-351.
(2021). 'The Predictive Value of Oral Nicorandil on Contrast Induced Nephropathy in Patients with Renal Insufficiency Undergoing Cardiac Catheterization in Non ST Segment Elevation Acute Coronary Syndrome', European Journal of Molecular & Clinical Medicine, 8(3), pp. 331-351.
The Predictive Value of Oral Nicorandil on Contrast Induced Nephropathy in Patients with Renal Insufficiency Undergoing Cardiac Catheterization in Non ST Segment Elevation Acute Coronary Syndrome. European Journal of Molecular & Clinical Medicine, 2021; 8(3): 331-351.
